Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats.

Posted on by

“Activation of cannabinoid CB(2) receptors suppresses neuropathic pain induced by traumatic nerve injury. The present studies were conducted to evaluate the efficacy of cannabinoid CB(2) receptor activation in suppressing painful peripheral neuropathy evoked by chemotherapeutic treatment with the antitumor agent paclitaxel…

 Our data suggest that cannabinoid CB(2) receptors may be important therapeutic targets for the treatment of chemotherapy-evoked neuropathy.”

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682949/

2 thoughts on “Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats.”

  2. This subject is dear to my heart as i suffer from peripheral neuropathy and alongside having diabetes.

    I found this article overwhelming but great to read and hopefully i can take some comfort away with me. Thanks for a lovely article.

    Reply ↓

Leave a Reply

Your email address will not be published. Required fields are marked *